Anthropic is operating a Bay Area wet biology lab that uses its AI models to run physical experiments, confirmed by TechCrunch. The lab has been running “today,” and Anthropic also bought Coefficient Bio in April to support its AI biotech work. The company is positioning the lab around fundamental biology while expanding access through its Life Sciences Verification Program and continuing partnerships rather than direct drug discovery.
Anthropic PBC opened a wet lab in the San Francisco Bay Area to use robots for biology research tasks. The robots will be powered by Claude, and Anthropic reported Claude Mythos 5.1 generated 12 candidate molecules with a 50% hit rate. The lab will likely use Claude with its MHS protocol to automate lab-instrument workflows and may involve external partners for some work.
The UK’s £500m Sovereign AI Fund is in talks to invest in London-based drug discovery startup Potential Sciences, which is reportedly raising money. The amount mentioned is £500m. If the talks go through, the startup would receive AI-funding to support its drug discovery work.
Amazon Bedrock AgentCore runtime was used to migrate a multi-model healthcare agent from self-managed deployment on Amazon ECS with AWS Fargate to a managed container that preserves the agent’s existing logic and multi-backend orchestration. Deployment takes about 10–15 minutes using the AgentCore CLI. Teams can reduce container lifecycle, scaling, identity, and observability work by letting AgentCore manage those operational concerns automatically while keeping triple-model orchestration and vector-enhanced retrieval.
European Innovation Council’s Tech Report 2026 identifies 25 early “technology signals” and Zubr Capital checks how many are turning into private-investable companies, with embodied AI standing out. Five independent private rounds in Q2 2026 backed European embodied AI companies, while other signals had fewer or no matching private bets. The result is a mapped shift from broad foresight to concrete investability when companies and sellable products (with clear buyers and next-cheque goals) emerge.
Every AI story that matters,
in your inbox by 8am.
TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the
day in two minutes. Follow companies and topics for alerts, or get the
briefing in Slack. Free, no spam, unsubscribe anytime.
Reading TLDRocket needs no cookies, and the readership counts we rely on come from
our own cookieless analytics. Google Analytics is the exception: it sets cookies and
reports to Google, so it stays switched off until you allow it. You can change your
mind any time from “Cookie settings” in the footer.
Strictly necessary
Session security and form protection (tldrocket-session,
XSRF-TOKEN, 2 hours). The site cannot work without them,
so they need no consent.
Always on
Google Analytics 4 (_ga,
_ga_<id>, up to 2 years). Measures which
stories and sections readers use. Google acts as a third-party processor and may
store the data outside the EU. No advertising, no profiling, no data sold.
